That Man May See, Inc.   Report issue

Foundation Phase 2
Founded: San Francisco CA United States

Organization Overview

First Clinical Trial
2007
NCT00557362
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

natamycin (natacyn) (1 trial)

voriconazole (vfend) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Keratitis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2